-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
net/tag_1553.
html" class="zdbq" title="Salmon related food information" target="_blank">salmon , AquaBounty has set its sights on "transgenic shrimp".
For AquaBounty Technologies, the successful sale of the first batch of genetically modified salmon to the North American market is an important milestone (previously reported that AquaBounty delivered the first batch of products to customers, and about 5 tons of AquAdvantage salmon were sold throughout the United States, or all of them entered the catering channel ), but this is far from the end.
There seems to be some "secret weapons" hidden in the breeding base of AquaBounty, which are not known to the outside world.
There seems to be some "secret weapons" hidden in the breeding base of AquaBounty, which are not known to the outside world.
In 2018, the Argentine Agricultural Biotechnology Committee exempted a gene-edited tilapia (FLT 01) developed by AquaBounty, saying that it does not contain foreign DNA and does not have to accept "special supervision" of genetically modified food.
According to AquaBounty, the meat yield of this genetically modified tilapia can be increased by 70%, and the feed conversion factor can be reduced by 14%.
According to AquaBounty, the meat yield of this genetically modified tilapia can be increased by 70%, and the feed conversion factor can be reduced by 14%.
"It can be tilapia, shrimp, or other fish.
" AquaBounty CEO Sylvia Wulf told UCN, "Although we have spent the longest time on salmon, we are also considering expanding the variety.
Scope.
We also have a lot of experience with shrimp.
When we first considered making salmon, we also considered making shrimp.
"
" AquaBounty CEO Sylvia Wulf told UCN, "Although we have spent the longest time on salmon, we are also considering expanding the variety.
Scope.
We also have a lot of experience with shrimp.
When we first considered making salmon, we also considered making shrimp.
"
Wulf revealed that for the breeding of shrimps, AquaBounty will focus on the growth rate, and may implant some "enhanced genes" that stimulate growth, which is similar to the development method of the AquAdvantage strain (AquAdvantage Atlantic salmon is implanted in the Pacific Ocean).
The growth hormone gene of Chinook salmon makes the growth rate faster).
The growth hormone gene of Chinook salmon makes the growth rate faster).
"At the technical level, we have mastered the land-based RAS system and know how to use the most advanced technology for routine breeding.
So, everything is possible.
" Wulf said.
So, everything is possible.
" Wulf said.
Wulf also mentioned that AquaBounty is negotiating a joint venture project with a number of potential partners to expand the production of AquAdvantage salmon and sell products to countries that are relatively "friendly" to genetic technology, such as Israel and China.
So far, AquaBounty has not really made a profit, and the loss in 2020 is about 16.
3 million US dollars.
However, Wulf emphasized that the company currently has sufficient book funds and has no plans to implement equity financing in the short term.
As long as the Kentucky farm in the United States is put into operation, it is expected to be profitable.
3 million US dollars.
However, Wulf emphasized that the company currently has sufficient book funds and has no plans to implement equity financing in the short term.
As long as the Kentucky farm in the United States is put into operation, it is expected to be profitable.
"We expect that the Kentucky farm will break ground within this year, and details such as the contractor and construction materials are still being discussed.
The construction period is expected to be 18-24 months, and the first batch of salmon will be harvested in 18 months.
"
The construction period is expected to be 18-24 months, and the first batch of salmon will be harvested in 18 months.
"
Wulf said that before and after the new crown epidemic, the American public's understanding of genetic engineering has changed.
This is due to the development of the new crown vaccine, because the mRNA vaccine itself is also a product of genetic technology.
"In the United States and Canada, the safety of genetic food has been repeatedly demonstrated.
As long as it is a product that can be marketed, it must have passed the most stringent review.
I hope genetic technology can resonate and eliminate consumer fear.
"
This is due to the development of the new crown vaccine, because the mRNA vaccine itself is also a product of genetic technology.
"In the United States and Canada, the safety of genetic food has been repeatedly demonstrated.
As long as it is a product that can be marketed, it must have passed the most stringent review.
I hope genetic technology can resonate and eliminate consumer fear.
"
